NSE · AI Signal & Stock Analysis · Neutral
As of Nov 13 2026, 6:15 AM, AkshayaAI's signal for CIPLA is Neutral → (mild move); technical trend raise-2026-10-30; trading at ₹1,408.30 (-0.82% today); neutral (RSI 62). AkshayaAI's signal, trend and forecast for CIPLA have been unchanged since 5 Nov 2026.
Data as of Nov 13 2026, 6:15 AM. Informational analytics only — not investment advice.
Instant, data-backed answers — free to try.
| AI signal | Neutral → · Mild move |
|---|---|
| Technical trend | RAISE-2026-10-30 |
| Price | ₹1,408.30 |
| Change today | -0.82% |
| RSI (14) | 62.30 |
| Relative volume | 1.61 |
| Composite (RMTPGV) score | 🔒 members |
| Market cap | ₹1.12 Lakh Cr |
| P/E | 38.83 |
| Cap category | Mega Cap |
| 52-week high | -7.4% away |
| 52-week low | +19.2% above |
| Delivery volume | — |
| Sector | Drug Manufacturers - Specialty & Generic |
As of Nov 13 2026, 6:15 AM, AkshayaAI's signal for CIPLA (Cipla Limited) is Neutral with a mild move, and its technical trend is raise-2026-10-30. The composite score and full factor breakdown are available to signed-in members.
CIPLA's RSI is neutral (RSI 62). A reading above 70 is typically overbought and below 30 oversold.
CIPLA is trading about 7% below its 52-week high and 19% above its 52-week low as of Nov 13 2026, 6:15 AM.
CIPLA's market capitalisation is ₹1.12 Lakh Cr as of Nov 13 2026, 6:15 AM.
CIPLA is classified under Drug Manufacturers - Specialty & Generic in AkshayaAI's taxonomy.
AkshayaAI refreshes its signals daily. The figures on this page are timestamped as of the latest run shown above.
No. AkshayaAI provides informational, AI-generated analytics for CIPLA — not personalised investment advice. Always do your own research.
AARTIPHARM · ABBOTINDIA · AJANTPHARM · AKUMS · ALIVUS · ALKEM
AkshayaAI provides AI-generated, informational stock analytics for US and India markets. This is not personalized investment advice. Figures are as of Nov 13 2026, 6:15 AM and may not reflect real-time prices. Always do your own research. How these signals work →